Cargando…

Symposium Title: Addiction treatment services during COVID 19 pandemic- Experience from a Community Drug Treatment Clinic in Delhi, India.

Opioid use disorders are one of the most serious global health problems. According to the latest national survey, current use of any opioid was 2.1% and an estimated 8.5 Lakh people who inject drugs (PWID) are in India. Opioid Agonist Treatment (OAT) is the most effective evidence-based strategy for...

Descripción completa

Detalles Bibliográficos
Autores principales: Bhad, Roshan, Yadav, Deepak, M B, Deepak, Rao, Ravindra
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9129623/
http://dx.doi.org/10.4103/0019-5545.341880
_version_ 1784712800441991168
author Bhad, Roshan
Yadav, Deepak
M B, Deepak
Rao, Ravindra
author_facet Bhad, Roshan
Yadav, Deepak
M B, Deepak
Rao, Ravindra
author_sort Bhad, Roshan
collection PubMed
description Opioid use disorders are one of the most serious global health problems. According to the latest national survey, current use of any opioid was 2.1% and an estimated 8.5 Lakh people who inject drugs (PWID) are in India. Opioid Agonist Treatment (OAT) is the most effective evidence-based strategy for management of opioid use disorders. In India, OAT is provided in government hospitals and through community-based OAT clinics. The covid-19 pandemic and nation-wide lockdown have adversely impacted OAT services delivery in the country. The National Drug Dependence Treatment Centre (NDDTC) runs a community drug treatment clinic in an urban impoverished area of East Delhi and provides low-threshold, free-of-cost OAT services for patients residing in the clinic’s vicinity. The clinic responded to the COVID-19 pandemic challenge and continued OAT throughout the pandemic by making substantial changes in its operations. This symposium shares the experience of NDDTC in running community-based OAT services using Clinical Workflow Automation based digital platform, teleconsultations, and various strategies adapted to deliver uninterrupted services during this unprecedented time. The feasibility, perceived satisfaction and retention rates of the patients receiving the tele medication assisted treatment offered is assessed among 100 patients will also be discussed. The various operational challenges faced and lessons learned during delivery of OAT services would also be discussed.
format Online
Article
Text
id pubmed-9129623
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Wolters Kluwer - Medknow
record_format MEDLINE/PubMed
spelling pubmed-91296232022-05-25 Symposium Title: Addiction treatment services during COVID 19 pandemic- Experience from a Community Drug Treatment Clinic in Delhi, India. Bhad, Roshan Yadav, Deepak M B, Deepak Rao, Ravindra Indian J Psychiatry Symposium Opioid use disorders are one of the most serious global health problems. According to the latest national survey, current use of any opioid was 2.1% and an estimated 8.5 Lakh people who inject drugs (PWID) are in India. Opioid Agonist Treatment (OAT) is the most effective evidence-based strategy for management of opioid use disorders. In India, OAT is provided in government hospitals and through community-based OAT clinics. The covid-19 pandemic and nation-wide lockdown have adversely impacted OAT services delivery in the country. The National Drug Dependence Treatment Centre (NDDTC) runs a community drug treatment clinic in an urban impoverished area of East Delhi and provides low-threshold, free-of-cost OAT services for patients residing in the clinic’s vicinity. The clinic responded to the COVID-19 pandemic challenge and continued OAT throughout the pandemic by making substantial changes in its operations. This symposium shares the experience of NDDTC in running community-based OAT services using Clinical Workflow Automation based digital platform, teleconsultations, and various strategies adapted to deliver uninterrupted services during this unprecedented time. The feasibility, perceived satisfaction and retention rates of the patients receiving the tele medication assisted treatment offered is assessed among 100 patients will also be discussed. The various operational challenges faced and lessons learned during delivery of OAT services would also be discussed. Wolters Kluwer - Medknow 2022-03 2022-03-24 /pmc/articles/PMC9129623/ http://dx.doi.org/10.4103/0019-5545.341880 Text en Copyright: © 2022 Indian Journal of Psychiatry https://creativecommons.org/licenses/by-nc-sa/4.0/This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.
spellingShingle Symposium
Bhad, Roshan
Yadav, Deepak
M B, Deepak
Rao, Ravindra
Symposium Title: Addiction treatment services during COVID 19 pandemic- Experience from a Community Drug Treatment Clinic in Delhi, India.
title Symposium Title: Addiction treatment services during COVID 19 pandemic- Experience from a Community Drug Treatment Clinic in Delhi, India.
title_full Symposium Title: Addiction treatment services during COVID 19 pandemic- Experience from a Community Drug Treatment Clinic in Delhi, India.
title_fullStr Symposium Title: Addiction treatment services during COVID 19 pandemic- Experience from a Community Drug Treatment Clinic in Delhi, India.
title_full_unstemmed Symposium Title: Addiction treatment services during COVID 19 pandemic- Experience from a Community Drug Treatment Clinic in Delhi, India.
title_short Symposium Title: Addiction treatment services during COVID 19 pandemic- Experience from a Community Drug Treatment Clinic in Delhi, India.
title_sort symposium title: addiction treatment services during covid 19 pandemic- experience from a community drug treatment clinic in delhi, india.
topic Symposium
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9129623/
http://dx.doi.org/10.4103/0019-5545.341880
work_keys_str_mv AT bhadroshan symposiumtitleaddictiontreatmentservicesduringcovid19pandemicexperiencefromacommunitydrugtreatmentclinicindelhiindia
AT yadavdeepak symposiumtitleaddictiontreatmentservicesduringcovid19pandemicexperiencefromacommunitydrugtreatmentclinicindelhiindia
AT mbdeepak symposiumtitleaddictiontreatmentservicesduringcovid19pandemicexperiencefromacommunitydrugtreatmentclinicindelhiindia
AT raoravindra symposiumtitleaddictiontreatmentservicesduringcovid19pandemicexperiencefromacommunitydrugtreatmentclinicindelhiindia